BR112015027974A2 - lâmina para aplicação cutânea contendo vitamina e ou um éster da mesma - Google Patents
lâmina para aplicação cutânea contendo vitamina e ou um éster da mesmaInfo
- Publication number
- BR112015027974A2 BR112015027974A2 BR112015027974A BR112015027974A BR112015027974A2 BR 112015027974 A2 BR112015027974 A2 BR 112015027974A2 BR 112015027974 A BR112015027974 A BR 112015027974A BR 112015027974 A BR112015027974 A BR 112015027974A BR 112015027974 A2 BR112015027974 A2 BR 112015027974A2
- Authority
- BR
- Brazil
- Prior art keywords
- ester
- containing vitamin
- silicone elastomer
- slide containing
- blade
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 title abstract 3
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- 229920002379 silicone rubber Polymers 0.000 abstract 3
- 229930003427 Vitamin E Natural products 0.000 abstract 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
- 229940046009 vitamin E Drugs 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000003607 modifier Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002759 woven fabric Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/06—Coatings containing a mixture of two or more compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Laminated Bodies (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
resumo de patente de invenção para: lâmina para aplicação cutânea contendo vitamina e ou um éster da mesma. a invenção refere-se a uma lâmina para aplicação cutânea, compreendendo uma camada de suporte feita de tecido frouxamente trançado incorporado em uma camada de elastômero de silicone, incorporando vitamina e ou um éster da mesma, em que a camada de elastômero de silicone tem uma espessura menor ou igual a 2,0 mm e o elastômero de silicone contém um modificador de elasticidade consistindo em um triglicerídeo de ácidos graxos c8-c18 saturados.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2013A000732 | 2013-05-06 | ||
IT000732A ITMI20130732A1 (it) | 2013-05-06 | 2013-05-06 | Lamina per applicazione cutanea contenente vitamina e o un suo estere |
PCT/EP2014/000979 WO2014180527A1 (en) | 2013-05-06 | 2014-04-11 | Sheet for cutaneous application containing vitamin e or an ester thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112015027974A2 true BR112015027974A2 (pt) | 2017-12-26 |
BR112015027974B1 BR112015027974B1 (pt) | 2020-10-06 |
BR112015027974B8 BR112015027974B8 (pt) | 2022-07-05 |
Family
ID=48628794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015027974A BR112015027974B8 (pt) | 2013-05-06 | 2014-04-11 | Lâmina para aplicação cutânea contendo vitamina e ou um éster da mesma |
Country Status (24)
Country | Link |
---|---|
US (2) | US9408827B2 (pt) |
EP (1) | EP2994172B1 (pt) |
CN (1) | CN105392503B (pt) |
AU (1) | AU2014264976B2 (pt) |
BR (1) | BR112015027974B8 (pt) |
CA (1) | CA2911264C (pt) |
CL (1) | CL2015003249A1 (pt) |
CY (1) | CY1120370T1 (pt) |
DK (1) | DK2994172T3 (pt) |
EA (1) | EA030832B1 (pt) |
ES (1) | ES2667171T3 (pt) |
HR (1) | HRP20180665T1 (pt) |
HU (1) | HUE038900T2 (pt) |
IT (1) | ITMI20130732A1 (pt) |
LT (1) | LT2994172T (pt) |
MX (1) | MX368262B (pt) |
NO (1) | NO2994172T3 (pt) |
PE (1) | PE20160114A1 (pt) |
PL (1) | PL2994172T3 (pt) |
PT (1) | PT2994172T (pt) |
RS (1) | RS57183B1 (pt) |
SA (1) | SA515370107B1 (pt) |
SI (1) | SI2994172T1 (pt) |
WO (1) | WO2014180527A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106512072A (zh) * | 2016-11-25 | 2017-03-22 | 江苏爱西施科技服务咨询股份有限公司 | 一种具有亲肤抗过敏的缝合线及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2192142B (en) * | 1986-07-04 | 1990-11-28 | Johnson & Johnson | Wound dressing |
US5652274A (en) * | 1991-03-01 | 1997-07-29 | Martin; Alain | Therapeutic-wound healing compositions and methods for preparing and using same |
IT1256170B (it) * | 1992-11-03 | 1995-11-29 | Medicazione per patologie cutanee | |
US5919476A (en) * | 1997-09-29 | 1999-07-06 | Pmt Corporation | Reinforced gel sheeting for scar treatment |
US6146664A (en) * | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
US6572878B1 (en) * | 2000-09-07 | 2003-06-03 | Robert Blaine | Method and device for treating scars |
US6495158B1 (en) * | 2001-01-19 | 2002-12-17 | Lec Tec Corporation | Acne patch |
MXPA05011947A (es) * | 2003-05-08 | 2006-02-02 | Procter & Gamble | Composiciones para el cuidado personal que comprenden un elastomero de silicona. |
JP2010529233A (ja) * | 2007-05-30 | 2010-08-26 | ダウ・コーニング・コーポレイション | 天然オイルから誘導されるシリコーンコポリマーおよびシリコーンエラストマー |
US20100003201A1 (en) * | 2008-07-07 | 2010-01-07 | Momentive Performance Materials, Inc. | Silicone composition |
DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
-
2013
- 2013-05-06 IT IT000732A patent/ITMI20130732A1/it unknown
- 2013-05-24 US US13/901,963 patent/US9408827B2/en active Active
-
2014
- 2014-04-11 LT LTEP14723701.0T patent/LT2994172T/lt unknown
- 2014-04-11 PL PL14723701T patent/PL2994172T3/pl unknown
- 2014-04-11 MX MX2015015344A patent/MX368262B/es active IP Right Grant
- 2014-04-11 EA EA201591905A patent/EA030832B1/ru not_active IP Right Cessation
- 2014-04-11 ES ES14723701.0T patent/ES2667171T3/es active Active
- 2014-04-11 HU HUE14723701A patent/HUE038900T2/hu unknown
- 2014-04-11 PT PT147237010T patent/PT2994172T/pt unknown
- 2014-04-11 CN CN201480025698.0A patent/CN105392503B/zh not_active Expired - Fee Related
- 2014-04-11 EP EP14723701.0A patent/EP2994172B1/en active Active
- 2014-04-11 BR BR112015027974A patent/BR112015027974B8/pt not_active IP Right Cessation
- 2014-04-11 RS RS20180440A patent/RS57183B1/sr unknown
- 2014-04-11 DK DK14723701.0T patent/DK2994172T3/en active
- 2014-04-11 NO NO14723701A patent/NO2994172T3/no unknown
- 2014-04-11 WO PCT/EP2014/000979 patent/WO2014180527A1/en active Application Filing
- 2014-04-11 PE PE2015002360A patent/PE20160114A1/es unknown
- 2014-04-11 SI SI201430699T patent/SI2994172T1/en unknown
- 2014-04-11 US US14/888,585 patent/US20160089471A1/en not_active Abandoned
- 2014-04-11 CA CA2911264A patent/CA2911264C/en active Active
- 2014-04-11 AU AU2014264976A patent/AU2014264976B2/en not_active Ceased
-
2015
- 2015-11-05 SA SA515370107A patent/SA515370107B1/ar unknown
- 2015-11-05 CL CL2015003249A patent/CL2015003249A1/es unknown
-
2018
- 2018-04-25 HR HRP20180665TT patent/HRP20180665T1/hr unknown
- 2018-04-30 CY CY20181100449T patent/CY1120370T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US9408827B2 (en) | 2016-08-09 |
MX2015015344A (es) | 2016-06-06 |
PL2994172T3 (pl) | 2018-07-31 |
DK2994172T3 (en) | 2018-05-07 |
ES2667171T3 (es) | 2018-05-09 |
CL2015003249A1 (es) | 2016-06-03 |
SA515370107B1 (ar) | 2018-01-23 |
PE20160114A1 (es) | 2016-02-28 |
US20140328885A1 (en) | 2014-11-06 |
MX368262B (es) | 2019-09-25 |
CA2911264C (en) | 2022-02-01 |
WO2014180527A1 (en) | 2014-11-13 |
RS57183B1 (sr) | 2018-07-31 |
CN105392503B (zh) | 2018-07-03 |
BR112015027974B8 (pt) | 2022-07-05 |
AU2014264976B2 (en) | 2017-02-02 |
ITMI20130732A1 (it) | 2014-11-07 |
LT2994172T (lt) | 2018-05-10 |
CN105392503A (zh) | 2016-03-09 |
CY1120370T1 (el) | 2019-07-10 |
EP2994172A1 (en) | 2016-03-16 |
US20160089471A1 (en) | 2016-03-31 |
EA201591905A1 (ru) | 2016-05-31 |
BR112015027974B1 (pt) | 2020-10-06 |
SI2994172T1 (en) | 2018-06-29 |
PT2994172T (pt) | 2018-05-07 |
CA2911264A1 (en) | 2014-11-13 |
HUE038900T2 (hu) | 2018-12-28 |
HRP20180665T1 (hr) | 2018-07-13 |
NO2994172T3 (pt) | 2018-06-30 |
EA030832B1 (ru) | 2018-10-31 |
AU2014264976A1 (en) | 2015-11-19 |
EP2994172B1 (en) | 2018-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015002710A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso. | |
CL2015003270A1 (es) | Composiciones y métodos para el suministro tópico de prostaglandinas a la grasa subcutanea. | |
ECSP12012097A (es) | Derivados de fumarato de ácido graso y sus usos | |
BR112016029465A2 (pt) | chapa de aço elétrica | |
BR112013017845A2 (pt) | agente antidiabético de abaixamento de lipídio | |
BR112014002769A2 (pt) | método e kit depilatório | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
BR112018003864A2 (pt) | método para preparação de uma composição de ácido hialurônico, composição, e, método para restauração de um tecido | |
CL2016000392A1 (es) | Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune | |
BR112017018838A2 (pt) | peptídeo possuindo atividade de branqueamento da pele e o uso do mesmo | |
BR112017006425A2 (pt) | derivado de isoxazol como inibidor de isocitrato desidrogenase 1 mutante | |
BR112016013881A2 (pt) | Membro para interface com um paciente, e interface com um paciente para a liberação de gás para um usuário | |
BR112016007487A2 (pt) | composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica | |
CL2016002400A1 (es) | Formulación para higiene personal | |
CL2016001098A1 (es) | Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales | |
ECSP16001672A (es) | Composición repelente de nematodos | |
BR112016013992A2 (pt) | Composição cosmética | |
BR112017007692A2 (pt) | composto que possui atividade de agonista de gpr119, método para preparar o mesmo e composição farmacêutica que inclui o mesmo como componente eficaz | |
BR112015027974A2 (pt) | lâmina para aplicação cutânea contendo vitamina e ou um éster da mesma | |
CL2015003460A1 (es) | Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica | |
AR076910A1 (es) | Un agente cosmetico de despigmentacion que comprende un carbohidrato de delta -tocoferilo | |
BR112017001372A2 (pt) | dispositivo médico com visibilidade melhorada para inserção em um corpo humano ou animal e/ou para o contato com tecido humano ou animal, e método de revestimento de um dispositivo médico | |
BR112015020182A2 (pt) | uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos | |
AR091705A1 (es) | Uso de cocet sulfato de zinc como agente antibacteriano contra propionibacterium acnes | |
CO2017003067A2 (es) | Compuestos de dipeptidil-cetoamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/04/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: HULKA S.R.L. (IT) |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2770 DE 06-02-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |